Epidemiology of Sjögren syndrome

被引:37
|
作者
Beydon, Maxime [1 ]
McCoy, Sara [2 ]
Nguyen, Yann [1 ,3 ]
Sumida, Takayuki [4 ]
Mariette, Xavier [1 ,3 ]
Seror, Raphaele [1 ,3 ]
机构
[1] Univ Paris Saclay, Bicetre AP HP Hop, Dept Rheumatol, Paris, France
[2] Univ Wisconsin Madison, Dept Med, Madison, WI USA
[3] Univ Paris Saclay, Ctr Immunol Viral Infect & Autoimmune Dis, INSERM U1184, Le Kremlin Bicetre, France
[4] Univ Tsukuba, Dept Internal Med, Tsukuba, Japan
关键词
PRIMARY SJOGRENS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NON-HODGKIN-LYMPHOMA; QUALITY-OF-LIFE; AUTOIMMUNE RHEUMATIC-DISEASES; CLASSIFICATION CRITERIA; SICCA SYMPTOMS; CLINICAL CHARACTERISTICS; FOLLOW-UP; INTERNATIONAL-CLASSIFICATION;
D O I
10.1038/s41584-023-01057-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjogren syndrome or in association with other connective tissue diseases (CTDs), including rheumatoid arthritis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The estimation of the prevalence and incidence of Sjogren syndrome varies depending on diagnostic criteria and study design, making it difficult to estimate geographical and temporal trends. Nonetheless, disease phenotype is influenced by geographical origin, which is a risk factor for systemic activity. Whether mortality in primary Sjogren syndrome is increased compared with that of the general population is not yet known, but extra-glandular manifestations, in particular lymphomas, are clear risk factors for mortality. In CTDs associated with Sjogren syndrome, lymphoma risk seems higher than that of patients with CTD alone, and there is potentially lower disease activity in SLE with Sjogren syndrome and in SSc with Sjogren syndrome than in SLE or SSc alone. In this epidemiological Review, the authors summarize the available evidence relating to the prevalence, incidence, risk factors and mortality associated with the autoimmune disorder Sjogren syndrome, with or without the co-occurrence of other connective tissue diseases. Primary Sjogren syndrome (pSS) affects mostly women, with age at disease onset as well as systemic activity varying according to geographical origin.Assessment of the prevalence of pSS varies according to study methodology, but can be estimated at between 0.01% and 0.05%, although some countries might be under-represented in this estimation.Mortality in pSS seems to be elevated predominantly in patients with extra-glandular manifestations, pulmonary involvement and non-Hodgkin lymphoma.pSS is the autoimmune disease with the most important increased risk of non-Hodgkin lymphoma, especially among patients with extra-glandular manifestations or systemic activity, low complement levels, cryoglobulinaemic vasculitis or rheumatoid factor positivity.Sjogren syndrome can be associated with other connective tissue diseases, mainly rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
引用
收藏
页码:158 / 169
页数:12
相关论文
共 50 条
  • [31] The role of epithelial cells in the immunopathogenesis of Sjögren's syndrome
    Tang, Yuan
    Zhou, Yingbo
    Wang, Xiaoran
    Che, Nan
    Tian, Jie
    Man, Kwan
    Rui, Ke
    Peng, Na
    Lu, Liwei
    JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 115 (01) : 57 - 67
  • [32] Update on Sjögren's syndrome Diagnostics, treatment, and challenges
    Zehrfeld, Nadine
    Witte, Torsten
    Ernst, Diana
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (03): : 217 - 228
  • [33] Inclusion body myositis associated with Sjögren’s syndrome
    Maria Misterska-Skóra
    Agata Sebastian
    Piotr Dzięgiel
    Maciej Sebastian
    Piotr Wiland
    Rheumatology International, 2013, 33 : 3083 - 3086
  • [34] JAK/STAT pathway targeting in primary Sjögren syndrome
    Gandolfo, Saviana
    Ciccia, Francesco
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2022, 3 (03): : 95 - 102
  • [35] OHIP-14 Scores in Patients with Sjögren's Syndrome Compared to Sicca Syndrome: A Systematic Review with Meta-Analysis
    Izzetti, Rossana
    Carli, Elisabetta
    Gennai, Stefano
    Graziani, Filippo
    Nisi, Marco
    INTERNATIONAL JOURNAL OF DENTISTRY, 2024, 2024
  • [36] Sjögren's syndrome: one year in review 2023
    Longhino, S.
    Chatzis, L. G.
    Dal Pozzolo, R.
    Peretti, S.
    Fulvio, G.
    La Rocca, G.
    Garcia, I. C. Navarro
    Orlandi, M.
    Quartuccio, L.
    Baldini, C.
    Bartoloni, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (12) : 2343 - 2356
  • [37] Obesity: Friend or Foe in Sjögren's Syndrome Patients?
    Mezei, Kincso
    Nagy, Laura
    Orosz, Viktoria
    Aradi, Zsofia
    Boi, Bernadett
    Szanto, Antonia
    DIAGNOSTICS, 2024, 14 (23)
  • [38] Salivary Gland Ultrasound in Primary Sj?gren?s Syndrome: Current and Future Perspectives
    Lorenzon, Michele
    Spina, Erica
    Di Franco, Francesco Tulipano
    Giovannini, Ivan
    De Vita, Salvatore
    Zabotti, Alen
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2022, 14 : 147 - 160
  • [39] Oral health-related quality of life in primary Sjögren's Syndrome
    Ingolotti, Lia
    Bejarano, Marisel
    Tamborenea, Natalia
    Merce, Aixa
    Arguissain, Constanza
    Martin, Luz
    Morbiducci, Julieta
    Azcona, Victoria
    Teplizky, Leandro
    Casals, Eugenia
    Hernandez, Adriana
    Marseillan, Mariana
    Secco, Anastasia
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2025, 30 (02): : e265 - e270
  • [40] Are there differences in the clinical and laboratory features of patients with seronegative primary Sjögren's syndrome?
    Yayla, Mucteba Enes
    Aksoy, Rahime
    Uslu, Emine
    Karaman, Zehra
    Yilmaz, Recep
    Ilbay, Ahmet
    Govec Giynas, Nilguen
    Gaydan, Abdulbaki
    Usta, Ahmet
    Mahmutoglu, Yeter
    Ates, Askin
    Turgay, Murat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024, 54 (05) : 956 - 962